Barclays
ONCS

Barclays’s OncoSec Medical Incorporated ONCS Stock Holding History

Barclays’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40
Closed -$4K – 5218
2021
Q1 		$4K Buy
+40
New +$5.47K ﹤0.01% 4515
2020
Q3 		– Hold
0
– – – 5864
2020
Q2 		– Hold
0
– – – 6593
2018
Q2 		– Sell
-1
Closed – – 7505
2018
Q1 		$0 Sell
1
-126
-99% -$51.7K ﹤0.01% 7530
2017
Q4 		$46K Buy
+127
New +$44.5K ﹤0.01% 5813

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Barclays's ONCS Position: Q2 2021 in Review

Barclays sold out of OncoSec Medical Incorporated (ONCS) in Q2 2021, closing a stake of 40 shares — an estimated $4K sold.

Barclays first reported a position in ONCS in Q4 2017 and held it in 3 quarters. The position peaked at $46K in Q4 2017. 35 funds tracked by Wall St. Rank hold ONCS as of Q2 2021.

  • Barclays reported no remaining OncoSec Medical Incorporated position as of Q2 2021 after selling out during the quarter.
  • Barclays sold 40 OncoSec Medical Incorporated shares in Q2 2021, an estimated $4K.
  • Barclays first reported a position in OncoSec Medical Incorporated in Q4 2017 and held it in 3 quarters.
  • Barclays's OncoSec Medical Incorporated position peaked at $46K in Q4 2017.
  • 35 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2021.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.